Literature DB >> 14711379

Small bowel gastrointestinal stromal tumours and ampullary cancer in Type 1 neurofibromatosis.

Kasim A Behranwala1, Duncan Spalding, Andrew Wotherspoon, Cyril Fisher, Jeremy N Thompson.   

Abstract

BACKGROUND: Type 1 neurofibromatosis (NF-1) is an autosomal dominant disorder with variable penetrance; approximately 50% of cases present as new mutations CASE REPORT: We report a case of a 56 year-old man with Von Recklinghausen's disease, carcinoma of the ampulla of Vater and incidental benign gastrointestinal stromal tumours of the jejunum.
CONCLUSIONS: Coexistence between ampullary carcinoid, ectopic pancreatic tissue in the jejunum and neurofibroma of the jejunum in NF-1 has been previously described however; the association of synchronous carcinoma of the ampulla of Vater and gastrointestinal stromal tumour of the jejunum in NF-1 has not been previously reported.

Entities:  

Year:  2004        PMID: 14711379      PMCID: PMC317374          DOI: 10.1186/1477-7819-2-1

Source DB:  PubMed          Journal:  World J Surg Oncol        ISSN: 1477-7819            Impact factor:   2.754


Background

Type 1 neurofibromatosis (NF-1) is an autosomal dominant disorder with variable penetrance; approximately 50% of the cases present as new mutations. The major diagnostic criterion includes multiple cutaneous neurofibromas, axillary or inguinal freckling, café au lait spots, Lisch nodules (pigmented iris hamartomas) and a first-degree family history of NF-1 [1]. The gene for NF-1 has been identified on chromosome 17. NF-1 gene encodes a GTPase activating protein that has the potential to regulate the activity of the p21 product of the ras oncogene and the gene has been suggested to play an important role in controlling cell proliferation and differentiation in a wide range of tissues [2]. Gastrointestinal tract lesions are not uncommon in NF-1, and typically vary from gut neural tissue hyperplasia to gastrointestinal stromal and endocrine cell tumours; there are only rare reports of a miscellaneous group of other malignant neoplasms [3]. Gastrointestinal stromal tumours (GIST) have been histologically identified as neurofibromas, leiomyomas, leiomyosarcomas, schwannomas, autonomic nerve tumours (GANT) and stromal tumours without any definite nerve or muscular differentiation, which have been hypothesised as originating from interstitial cells of Cajal (ICC) [3-6]. Gastrointestinal lesions associated with NF-1, although usually asymptomatic, may present as abdominal pain, dyspepsia, vomiting, anaemia, melaena, haematemesis, haematochezia, intussusception, volvulus, small bowel obstruction, fever and abdominal mass. The case reported by Karatzas et al., [7] mentions the coexistence between ampullary carcinoid, ectopic pancreatic tissue in the jejunum and neurofibroma of the jejunum in NF-1. The association of synchronous carcinoma of the ampulla of Vater and gastrointestinal stromal tumour of the jejunum in NF-1 has not been previously described.

Case Report

A 56-year-old man presented with history of obstructive jaundice. ERCP done two months earlier at the referring hospital showed a distal bile duct stricture that was stented. Jaundice had initially improved but recurred due to stent occlusion. Skin examination was remarkable for diffuse cutaneous neurofibromas and café au lait spots. CT scan showed a mass lesion in pancreatic head with no evidence of metastatic disease elsewhere. There was no histological/cytological diagnosis before the operation. With a provisional diagnosis of carcinoma head of the pancreas patient underwent laparotomy. At laparotomy, several nodules were seen on the serosal surface of the small bowel of which three yellowish serosal nodules from the jejunum were excised. A pylorus-preserving proximal pancreatic-duodenectomy was performed. Pathological examination of the resected pancreas showed a 33 mm, moderately differentiated invasive adenocarcinoma (Figure 1), arising from a severely dysplastic villous adenoma of the ampulla. Two intra-pancreatic lymph nodes showed metastatic carcinoma with extranodal spread (pT4N1bM0). The three small bowel serosal nodules were less than 5 mm in size and had similar appearances. Microscopically the lesions were composed of bland spindle cells arranged in a storiform pattern set within muscle wall (Figure 2a). No necrosis, mitotic figures or pleomorphism was seen. Tumour cells were positive for CD117 (Figure 2b) and CD34 (Figure 2d) but were negative for S100 protein (Figure 2c), neurofilament, synaptophysin, desmin, smooth muscle actin and calponin. These features were of benign gastrointestinal stromal tumours.
Figure 1

Photomicrograph showing pancreatic adenocarcinoma (Haematoxylin and Eosin × 100)

Figure 2

Photomicrograph showing Gastrointestinal stromal tumours a) Bland spindle cells arranged in a storiform pattern set within muscle wall with no necrosis, mitotic figures or pleomorphism seen. (Haematoxylin and Eosin × 100) b) Positive staining with CD 117 (×100) c) Negative staining with S100 (× 100) d) Positive staining with CD34 (× 100)

Photomicrograph showing pancreatic adenocarcinoma (Haematoxylin and Eosin × 100) Photomicrograph showing Gastrointestinal stromal tumours a) Bland spindle cells arranged in a storiform pattern set within muscle wall with no necrosis, mitotic figures or pleomorphism seen. (Haematoxylin and Eosin × 100) b) Positive staining with CD 117 (×100) c) Negative staining with S100 (× 100) d) Positive staining with CD34 (× 100) Postoperative period was uneventful. The patient was offered adjuvant therapy but refused it. Local recurrence was detected at one-year follow-up.

Discussion

Gastrointestinal (GI) involvement in von Recklinghausen's disease occurs in three principal forms i) hyperplasia of the submucosal and myenteric nerve plexuses and mucosal ganglioneuromatosis, which leads to disordered gut motility; ii) gastrointestinal stromal tumours showing varying degrees of neural or smooth muscle differentiation; and iii) a distinctive glandular, somatostatin-rich carcinoid in periampullary region of the duodenum that contains psammoma bodies and may be associated with phaeochromocytoma. NF-1 gene mutations involve GTPase activating protein-coding sequences. Aberrations in other parts of NF1 gene, or in other genes, may also be involved in the development of the varied clinical manifestations. GISTs are the most common mesenchymal tumours of the gastrointestinal (GI) tract. They are defined as c-kit (CD117, stem cell/ mast cell growth factor receptor)-positive mesenchymal spindle cell, epithelioid or rarely pleomorphic neoplasms arising primarily in the gastrointestinal tract, omentum, and mesentery [8]. A distinctive histological finding, principally in lesions of the small intestine, is presence of scattered eosinophilic bodies that range from 35 to 50 μm in size. These stain with PAS and Masson's trichrome, and are interpreted as skeinoid fibres, the distinctive extracellular collagen globules originally described by Min [9]. Tumours with a high mitotic index (>5 mitoses/10 HPF), measuring more than 5 cms in diameter and extra-gastrointestinal spread are considered malignant [10,11]. DNA studies show benign tumours to be euploid while the malignant tumours are aneuploid [12]. Intra-abdominal spread or liver metastasis occurs in 10%–30%. The association of GIST with NF-1, skeinoid fibres and an ultrastructure suggestive of partial neural differentiation, could indicate a mixed neural ICC related phenotype or the possibility of ICC having neural phenotype [4]. GISTs differ clinically and pathogenetically from true leiomyosarcomas (rare in the GI tract) and leiomyomas. The latter occur in the GI tract, predominantly in the oesophagus (intramural tumours) and the colon and rectum (muscularis mucosae tumours). GISTs differ histologically, immunohistochemically and genetically from typical (oesophageal) leiomyomas that are negative for c-kit and CD34 and show neither DNA-loss at 14q, nor c-kit mutations. Schwannomas on the other hand are S100-positive benign spindle cell tumours and usually occur in stomach. GI autonomic nerve tumours (GANTs) are probably a subset of GIST, while angiosarcomas and metastatic melanomas, both of which are often c-kit positive should not be confused with GISTs [13]. Niv Y et al have reported a case of pancreatic cancer, duodenal cancer and liver metastasis in a patient with neurofibromatosis [14]. Though biopsies from all these lesions showed adenocarcinoma, the organ of origin could not be ascertained in their study [14]. Management of synchronous tumours present as a diagnostic and therapeutic dilemma, it is important to accurately distinguish between GIST, carcinoid tumours, and adenocarcinoma as the prognosis of these tumours differs significantly. Small benign tumours are often found incidentally during unrelated surgery or autopsy [15] as in the present case. As the occurrence is rare the optimal management still eludes surgeons.
  15 in total

1.  Ampullary carcinoid and jejunal stromal tumour associated with von Recklinghausen's disease presenting as gastrointestinal bleeding and jaundice.

Authors:  G Karatzas; G Kouraklis; A Karayiannakis; P Patapis; N Givalos; E Kaperonis
Journal:  Eur J Surg Oncol       Date:  2000-06       Impact factor: 4.424

2.  Adenocarcinoma of pancreas and duodenum associated with cutaneous neurofibromatosis.

Authors:  Y Niv; S Abu-Avid; M Oren
Journal:  Am J Med       Date:  1987-02       Impact factor: 4.965

Review 3.  Von Recklinghausen neurofibromatosis.

Authors:  V M Riccardi
Journal:  N Engl J Med       Date:  1981-12-31       Impact factor: 91.245

4.  Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors.

Authors:  K Sircar; B R Hewlett; J D Huizinga; K Chorneyko; I Berezin; R H Riddell
Journal:  Am J Surg Pathol       Date:  1999-04       Impact factor: 6.394

5.  Multiple small intestinal stromal tumours in a patient with previously unrecognised neurofibromatosis type 1: immunohistochemical and ultrastructural evaluation.

Authors:  R Boldorini; A Tosoni; M Leutner; R Ribaldone; N Surico; E Comello; K W Min
Journal:  Pathology       Date:  2001-08       Impact factor: 5.306

6.  Gastrointestinal stromal tumours: evaluation of biological and clinical current opinions.

Authors:  Gian Luigi Adani; Daniele Marcello; Andrea Sanna; Jacopo Mazzetti; Gabriele Anania; Annibale Donini
Journal:  Chir Ital       Date:  2002 Mar-Apr

7.  [Gastrointestinal stromal tumors. Observations on the basis of 29 cases].

Authors:  Z Sápi; R B Kovács; M Bodó
Journal:  Orv Hetil       Date:  2001-11-11       Impact factor: 0.540

Review 8.  Diagnosis of gastrointestinal stromal tumors: a consensus approach.

Authors:  Christopher D M Fletcher; Jules J Berman; Christopher Corless; Fred Gorstein; Jerzy Lasota; B Jack Longley; Markku Miettinen; Timothy J O'Leary; Helen Remotti; Brian P Rubin; Barry Shmookler; Leslie H Sobin; Sharon W Weiss
Journal:  Int J Surg Pathol       Date:  2002-04       Impact factor: 1.271

Review 9.  Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics.

Authors:  Markku Miettinen; Jerzy Lasota
Journal:  Pol J Pathol       Date:  2003       Impact factor: 1.072

Review 10.  Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review.

Authors:  Markku Miettinen; Mourad Majidi; Jerzy Lasota
Journal:  Eur J Cancer       Date:  2002-09       Impact factor: 9.162

View more
  13 in total

1.  Gastrointestinal stromal tumors (GISTs): an imaging perspective.

Authors:  Shahina Bano; Sunil Kumar Puri; Lalendra Upreti; Vikas Chaudhary; Hridesh Kumar Sant; Ranjana Gondal
Journal:  Jpn J Radiol       Date:  2011-12-22       Impact factor: 2.374

2.  Gastrointestinal bleeding and cutaneous nodules.

Authors:  Alka Mittal; Daniel Felter; S Michelle Shiller; A David McCollum; Jeffrey P Lamont; Damien Mallat
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-07

3.  Multiple gastrointestinal stromal tumors of the ileum and neurofibromatosis type 1.

Authors:  Marcelo A Beltran; Karina S Cruces; Carlos Barría; Gustavo Verdugo
Journal:  J Gastrointest Surg       Date:  2006-02       Impact factor: 3.452

Review 4.  Periampullary and duodenal neoplasms in neurofibromatosis type 1: two cases and an updated 20-year review of the literature yielding 76 cases.

Authors:  Daniel Relles; Jennie Baek; Agnieszka Witkiewicz; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2010-03-19       Impact factor: 3.452

5.  Synchronous adenocarcinoma and gastrointestinal stromal tumors in the stomach.

Authors:  Rong Cai; Gang Ren; Deng-Bin Wang
Journal:  World J Gastroenterol       Date:  2013-05-28       Impact factor: 5.742

6.  Obstructive jaundice secondary to ampullary adenocarcinoma in neurofibromatosis type 1.

Authors:  Gurushantappa Yalagachin; Prakash Mahantshetti
Journal:  Indian J Surg       Date:  2012-05-06       Impact factor: 0.656

7.  Ampullary somatostatinomas and jejunal gastrointestinal stromal tumor in a patient with Von Recklinghausen's disease.

Authors:  Rossella Bettini; Massimo Falconi; Stefano Crippa; Paola Capelli; Letizia Boninsegna; Paolo Pederzoli
Journal:  World J Gastroenterol       Date:  2007-05-21       Impact factor: 5.742

8.  c-KIT positive Gastrointestinal Stromal Tumor presenting with acute bleeding in a patient with neurofibromatosis type 1: a case report.

Authors:  Esam Aboutaleb; Manish Kothari; Osama Damrah; Roben Canelo
Journal:  Int Semin Surg Oncol       Date:  2009-10-23

9.  Coexistence of gastrointestinal stromal tumors with other neoplasms.

Authors:  Łukasz Liszka; Ewa Zielińska-Pajak; Jacek Pajak; Dariusz Gołka; Joanna Huszno
Journal:  J Gastroenterol       Date:  2007-08-24       Impact factor: 7.527

10.  Major and Minor Duodenal Papilla Neuroendocrine Tumors in Type 1 Neurofibromatosis: Case Report.

Authors:  M R Zandomeni; M Chahdi Beltrame; M de Santibañes; O Mazza; J Pekolj; E de Santibañes; R Sanchez Claria
Journal:  J Gastrointest Cancer       Date:  2018-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.